Clinical efficacy and cost-effectiveness of HP-human FSH (Fostimon®) versus rFSH (Gonal-F®) in IVF-ICSI cycles: a meta-analysis

By Gerli Sandro  

Gynecological Endocrinology, Vol. 29, Iss. 6, 2013-06 ,pp. : 520-529

Informa Healthcare

Access to resources Recommend Favorite

Meta‐analysis of recombinant versus urinary‐derived FSH: an update

By Al‐Inany Hesham   Aboulghar Mohamed   Mansour Ragaa   Serour Gamal  

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study

By la Cour Freiesleben N.   Lossl K.   Bogstad J.   Bredkjr H.E.   Toft B.   Rosendahl M.   Loft A.   Bangsboll S.   Pinborg A.   Nyboe Andersen A.  

Human Reproduction, Vol. 24, Iss. 10, 2009-10 ,pp. : 2523-2530

Oxford University Press

Access to resources Recommend Favorite

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial

By De Placido G.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 390-396

Oxford University Press

Access to resources Recommend Favorite

Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study

By Kocak Muberra   Dilbaz Berna   Demır Berfu   Taşci Yasemın   Tarcan Aytül   Dede Suat   Haberal Alı  

Gynecological Endocrinology, Vol. 26, Iss. 6, 2010-06 ,pp. : 429-434

Informa Healthcare

Access to resources Recommend Favorite